Etanercept treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis-Reference-Cited by-同舟云学术

Etanercept treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis

Published:2022-09 Issue:3 Volume:129 Page:360-365.e1
ISSN:1081-1206
Container-title:Annals of Allergy, Asthma & Immunology
language:en
Short-container-title:Annals of Allergy, Asthma & Immunology

Author:

Tian Cui-Cui,Ai Xue-Chen,Ma Jian-Chi,Hu Feng-Qiu,Liu Xiu-Ting,Luo Yi-Jin,Tan Guo-Zhen,Zhang Jun-Min,Li Xi-Qing,Guo Qing,Zeng Fan-Qin,Shi Zhen-Rui,Wang Liangchun^ORCID

Funder

Basic and Applied Basic Research Foundation of Guangdong Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology

Reference40 articles.

1. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study;Mockenhaupt;J Invest Dermatol,2008

2. Severe cutaneous adverse drug reactions;Chung;J Dermatol,2016

3. Severe cutaneous adverse reactions to drugs;Duong;Lancet,2017

4. The medication risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in Asians: the major drug causality and comparison with the US FDA label;Wang;Clin Pharmacol Ther,2019

5. Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis;Lerch;Clin Rev Allergy Immunol,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor necrosis factor inhibitors enhance corticosteroid therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis linked to immune checkpoint inhibitors: a prospective study;Frontiers in Immunology;2024-08-07

2. Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy;Seminars in Cancer Biology;2024-06

3. Severe cutaneous adverse reactions;Nature Reviews Disease Primers;2024-04-25

4. Effectiveness of early treatment with plasma exchange in patients with Stevens–Johnson syndrome and toxic epidermal necrolysis;Scientific Reports;2024-02-05

5. Etanercept treatment for pediatric toxic epidermal necrolysis induced by deflazacort: a case report and literature review;Frontiers in Immunology;2024-01-25